AbbVie (ABBV) Stock Analysis

June 13, 2026

Here is a fundamental analysis of AbbVie (ABBV), benchmarking its profitability, financial strength, dividend and valuation against its industry group peers.

Performance

Cumulative Growth

ABBV

GSPC

AbbVie (ABBV) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and S&P 500 (GSPC). Returns over one year are annualized.

Performance at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
1-Year Return	22.21%	44.56%

Risk

Drawdown

ABBV

GSPC

AbbVie (ABBV) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Risk at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
1-Year Volatility	24.36%	67.11%
Beta	0.31	0.93

Company Profile

Company profile fields for AbbVie (ABBV)
Profile Item	ABBV
Name	AbbVie Inc.
Country/Region	United States
GICS Sector	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Biotechnology
GICS Sub-Industry	Biotechnology
Market Capitalization	402.35 billion USD
Currency	USD
Exchange	NYSE
Listing Date	January 2, 2013
Security Type	Common Stock

Valuation

Price-to-Earnings Ratio (TTM)

AbbVie (ABBV) trades at P/E ratio of 111.09, above the peer range for its industry. The market is paying unusually heavily for TTM earnings relative to comparable companies.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

111.09

Group distribution

ABBV: 111.09
Max: 77.14
Q3: 43.78
Median: 24.68
Q1: 15.27
Min: 1.70

Largest peers

ABBV: 111.09
LLY: 40.32
MRK: 33.54
JNJ: 27.94
AZN: 26.96
NVS: 21.93
NVO: 10.30

Where AbbVie (ABBV) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Price-to-Sales Ratio (TTM)

AbbVie (ABBV) trades at 6.40 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.40

Group distribution

Max: 55.38
Q3: 24.42
Median: 6.98
ABBV: 6.40
Q1: 3.30
Min: 0.01

Largest peers

LLY: 13.98
ABBV: 6.40
JNJ: 6.02
NVS: 5.16
AZN: 4.59
MRK: 4.47
NVO: 0.59

Where AbbVie (ABBV) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Price-to-Book Ratio (MRQ)

AbbVie (ABBV) has negative P/B ratio of -60.45, which means reported book equity is negative. Price-to-book breaks down in this situation and should not be used as a valuation signal.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-60.45

Group distribution

Max: 13.23
Q3: 6.38
Median: 3.46
Q1: 1.64
Min: -5.17
ABBV: -60.45

Largest peers

LLY: 32.45
NVS: 7.58
JNJ: 7.14
MRK: 6.41
NVO: 6.22
AZN: 5.85
ABBV: -60.45

Where AbbVie (ABBV) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
Price-to-Earnings Ratio (TTM)	111.09	24.68
Price-to-Sales Ratio (TTM)	6.40	6.98
Price-to-Book Ratio (MRQ)	-60.45	3.46
Free Cash Flow Yield	5.17%	-2.37%

Profitability

Return on Equity (TTM)

No usable ROE is available for AbbVie (ABBV) this period, so the shareholder-equity return read is skipped.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Group distribution

Max: 101.32%
Q3: 2.92%
Median: -31.26%
Q1: -62.68%
Min: -158.89%
ABBV: --

Largest peers

LLY: 107.46%
NVO: 71.40%
NVS: 34.93%
JNJ: 26.42%
AZN: 23.48%
MRK: 18.94%
ABBV: --

AbbVie (ABBV) doesn’t report ROE this period; the box shows the Pharmaceuticals, Biotechnology & Life Sciences group’s distribution and the dots its largest members.

Net Profit Margin (TTM)

AbbVie (ABBV) keeps 5.79% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.79%

Group distribution

Max: 12.76%
ABBV: 5.79%
Q3: 4.00%
Median: 0.00%
Q1: -2.26%
Min: -11.53%

Largest peers

NVO: 37.21%
LLY: 34.99%
NVS: 23.92%
JNJ: 21.83%
AZN: 17.19%
MRK: 13.59%
ABBV: 5.79%

Where AbbVie (ABBV) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Profit Margin (TTM)

AbbVie (ABBV) turns 32.16% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.16%

Group distribution

Max: 100.30%
ABBV: 32.16%
Q3: 4.40%
Median: 0.00%
Q1: -131.52%
Min: -333.43%

Largest peers

NVO: 61.57%
LLY: 49.39%
MRK: 38.60%
ABBV: 32.16%
NVS: 30.48%
AZN: 27.94%
JNJ: 27.41%

Where AbbVie (ABBV) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
Return on Equity (TTM)	--	-31.26%
Return on Assets (TTM)	10.03%	-14.70%
Net Profit Margin (TTM)	5.79%	0.00%
Operating Profit Margin (TTM)	32.16%	0.00%
Gross Profit Margin (TTM)	72.03%	33.58%

Financial Strength

Current Ratio (MRQ)

AbbVie (ABBV) has current ratio of 0.80, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.80

Group distribution

Max: 24.81
Q3: 11.75
Median: 5.57
Q1: 2.69
ABBV: 0.80
Min: 0.23

Largest peers

LLY: 1.50
MRK: 1.30
JNJ: 1.03
AZN: 0.91
NVS: 0.85
ABBV: 0.80
NVO: 0.79

Where AbbVie (ABBV) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt-to-Equity Ratio (MRQ)

No usable debt-to-equity ratio is available for AbbVie (ABBV) this period, so the balance-sheet leverage read is skipped.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Group distribution

Max: 1.60
Q3: 0.68
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

Largest peers

LLY: 1.39
NVS: 1.21
MRK: 1.07
NVO: 0.72
AZN: 0.72
JNJ: 0.68
ABBV: --

AbbVie (ABBV) doesn’t report debt-to-equity ratio this period; the box shows the Pharmaceuticals, Biotechnology & Life Sciences group’s distribution and the dots its largest members.

Financial Strength at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
Current Ratio (MRQ)	0.80	5.57
Debt-to-Equity Ratio (MRQ)	--	0.15
Net Debt / EBITDA	2.12	1.09

Dividends

Dividend Yield (TTM)

AbbVie (ABBV) has dividend yield of 3.04%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.04%

Group distribution

ABBV: 3.04%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

NVO: 4.11%
NVS: 3.10%
ABBV: 3.04%
MRK: 2.86%
JNJ: 2.23%
AZN: 1.77%
LLY: 0.61%

Where AbbVie (ABBV) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) has payout ratio of 325.98%, meaning dividends exceeded current-period earnings. The gap would need to be covered by cash, retained earnings, financing, or other sources, so earnings alone do not support the payout.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

325.98%

Group distribution

ABBV: 325.98%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

ABBV: 325.98%
MRK: 93.52%
NVS: 67.91%
JNJ: 60.25%
AZN: 47.70%
NVO: 42.59%
LLY: 22.13%

Where AbbVie (ABBV) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividends at a Glance

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: ABBV	Industry group median
Dividend Yield (TTM)	3.04%	0.00%
Dividend Payout Ratio (TTM)	325.98%	0.00%